2025 ahead ayondo Franchise coming soon
Happy 
xMas Holidays
xMas Holidays
xMas Holidays
GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.
Borregaard has today extended the bilateral multicurrency revolving credit facility agreement with DNB Bank ASA. The facility is for general corporate purposes and amounts to NOK 500 million with a tenor of three years.
Borregaard’s operating revenues were NOK 1,949 million (NOK 1,714 million)2 in the 3rd quarter of 2024. EBITDA1 reached NOK 524 million (NOK 482 million). The result in both BioSolutions and Fine Chemicals increased while the result in BioMaterials was lower compared with the 3rd quarter of 2023.
Borregaard and the Norwegian hydropower producer Hafslund have entered into a new long-term power purchase agreement, for the period 2025 to 2034. The annual contract volume is 88 GWh, representing 10–15% of the Sarpsborg site’s annual consumption.
Borregaard’s Capital Markets Day (CMD) will take place today at Oslo Concert Hall, starting at 09:00 and ending at 12:30 CEST. The event can be followed via webcast (https://www.borregaard.com/investors/ir-news/capital-markets-day-2024/). The written material supporting the presentations is enclosed.
Today, Sveinung Heggen, General Counsel, exercised 15,000 stock options at a strike price of NOK 87.60 per share and in separate transactions, purchased and sold the same number of shares.
Borregaard’s operating revenues were NOK 1,949 million (NOK 1,963 million)2 in the 2nd quarter of 2024. EBITDA1 was NOK 510 million (NOK 537 million). The result in BioSolutions increased while the result in BioMaterials was lower compared with the 2nd quarter of 2023. Fine Chemicals delivered a strong result slightly below the same quarter last year.
P R O D U C T S U G G E S T I O N S
